These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23613563)

  • 21. Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Cell Immunol; 2019 Feb; 336():12-19. PubMed ID: 30545568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic agonists activate P2X7 receptors to stimulate protein secretion by the rat lacrimal gland.
    Dartt DA; Hodges RR
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3381-90. PubMed ID: 21421880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats.
    Klaft ZJ; Schulz SB; Maslarova A; Gabriel S; Heinemann U; Gerevich Z
    Epilepsia; 2012 Nov; 53(11):1978-86. PubMed ID: 23106524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of P2X7 receptors decreases the proliferation of murine luteal cells.
    Wang J; Liu S; Nie Y; Wu B; Wu Q; Song M; Tang M; Xiao L; Xu P; Tan X; Zhang L; Li G; Liang S; Zhang C
    Reprod Fertil Dev; 2015 Nov; 27(8):1262-71. PubMed ID: 25782073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
    Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of alpha1D-adrenergic and P2X(7) receptors in the rat lacrimal gland and the effect on intracellular [Ca2+] and protein secretion.
    Dartt DA; Hodges RR
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5720-9. PubMed ID: 21685341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2X7 receptor antagonists protect against N-methyl-D-aspartic acid-induced neuronal injury in the rat retina.
    Sakamoto K; Endo K; Suzuki T; Fujimura K; Kurauchi Y; Mori A; Nakahara T; Ishii K
    Eur J Pharmacol; 2015 Jun; 756():52-8. PubMed ID: 25796199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
    FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
    Pelegrin P
    Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of P2X7 antagonists with a focus on CNS indications.
    Rech JC; Bhattacharya A; Letavic MA; Savall BM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons.
    Ortega F; Pérez-Sen R; Delicado EG; Teresa Miras-Portugal M
    Neuropharmacology; 2011 Dec; 61(8):1210-21. PubMed ID: 21798274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy.
    Sarti AC; Vultaggio-Poma V; Di Virgilio F
    Purinergic Signal; 2021 Jun; 17(2):175-178. PubMed ID: 33818742
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of the P2X7 receptor reduces cystogenesis in PKD.
    Chang MY; Lu JK; Tian YC; Chen YC; Hung CC; Huang YH; Chen YH; Wu MS; Yang CW; Cheng YC
    J Am Soc Nephrol; 2011 Sep; 22(9):1696-706. PubMed ID: 21636640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of islet allograft primary nonfunction.
    Liu M; Shapiro ME
    Transplant Proc; 1995 Dec; 27(6):3205-7. PubMed ID: 8539915
    [No Abstract]   [Full Text] [Related]  

  • 35. AZD-9056, a P2X7 receptor inhibitor, suppresses ATP-induced melanogenesis.
    Kim JY; Lee EJ; Seong YJ; Ahn Y; Park S; Lee J; Oh SH
    J Dermatol Sci; 2020 Dec; 100(3):227-229. PubMed ID: 33051087
    [No Abstract]   [Full Text] [Related]  

  • 36. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
    Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P2X7 receptor in cardiovascular disease: The heart side.
    Guerra Martinez C
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP-P2X7 receptor signaling controls basal and TNFα-stimulated glial cell proliferation.
    Zou J; Vetreno RP; Crews FT
    Glia; 2012 Apr; 60(4):661-73. PubMed ID: 22298391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons.
    Sánchez-Nogueiro J; Marín-García P; Bustillo D; Olivos-Oré LA; Miras-Portugal MT; Artalejo AR
    Eur J Pharmacol; 2014 Dec; 744():190-202. PubMed ID: 25446427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the purinergic signaling in epilepsy.
    Cieślak M; Wojtczak A; Komoszyński M
    Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.